nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP2C9—brain cancer	0.589	1	CbGaD
Bicalutamide—CYP2D6—Lomustine—brain cancer	0.0769	0.303	CbGbCtD
Bicalutamide—CYP2D6—Hydroxyurea—brain cancer	0.0582	0.23	CbGbCtD
Bicalutamide—CYP3A4—Temozolomide—brain cancer	0.0575	0.227	CbGbCtD
Bicalutamide—CYP3A4—Lomustine—brain cancer	0.0489	0.193	CbGbCtD
Bicalutamide—CYP3A4—Etoposide—brain cancer	0.0118	0.0466	CbGbCtD
Bicalutamide—Enzalutamide—CYP2C9—brain cancer	0.00371	1	CrCbGaD
Bicalutamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000919	0.0648	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.000846	0.0596	CbGpPWpGaD
Bicalutamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000836	0.0589	CbGpPWpGaD
Bicalutamide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000712	0.0502	CbGpPWpGaD
Bicalutamide—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000655	0.0462	CbGpPWpGaD
Bicalutamide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000441	0.0311	CbGpPWpGaD
Bicalutamide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000424	0.0299	CbGpPWpGaD
Bicalutamide—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000406	0.0286	CbGpPWpGaD
Bicalutamide—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00039	0.0275	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.00037	0.0261	CbGpPWpGaD
Bicalutamide—Syncope—Procarbazine—brain cancer	0.000364	0.00261	CcSEcCtD
Bicalutamide—Haemoglobin—Hydroxyurea—brain cancer	0.000362	0.0026	CcSEcCtD
Bicalutamide—Haemorrhage—Hydroxyurea—brain cancer	0.000361	0.00258	CcSEcCtD
Bicalutamide—Cardiac failure congestive—Etoposide—brain cancer	0.000359	0.00258	CcSEcCtD
Bicalutamide—Muscular weakness—Temozolomide—brain cancer	0.000359	0.00257	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000359	0.00257	CcSEcCtD
Bicalutamide—Loss of consciousness—Procarbazine—brain cancer	0.000356	0.00256	CcSEcCtD
Bicalutamide—Cough—Procarbazine—brain cancer	0.000354	0.00254	CcSEcCtD
Bicalutamide—Dysphagia—Temozolomide—brain cancer	0.000352	0.00252	CcSEcCtD
Bicalutamide—Hypertension—Procarbazine—brain cancer	0.00035	0.00251	CcSEcCtD
Bicalutamide—Myalgia—Procarbazine—brain cancer	0.000345	0.00247	CcSEcCtD
Bicalutamide—Anxiety—Procarbazine—brain cancer	0.000344	0.00247	CcSEcCtD
Bicalutamide—Neutropenia—Carmustine—brain cancer	0.000341	0.00244	CcSEcCtD
Bicalutamide—Bronchitis—Temozolomide—brain cancer	0.000338	0.00243	CcSEcCtD
Bicalutamide—Dry mouth—Procarbazine—brain cancer	0.000338	0.00242	CcSEcCtD
Bicalutamide—Cardiac failure—Etoposide—brain cancer	0.000334	0.00239	CcSEcCtD
Bicalutamide—Confusional state—Procarbazine—brain cancer	0.000334	0.00239	CcSEcCtD
Bicalutamide—Vomiting—Lomustine—brain cancer	0.000331	0.00238	CcSEcCtD
Bicalutamide—Oedema—Procarbazine—brain cancer	0.000331	0.00237	CcSEcCtD
Bicalutamide—Neutropenia—Temozolomide—brain cancer	0.000329	0.00236	CcSEcCtD
Bicalutamide—Dysuria—Temozolomide—brain cancer	0.000329	0.00236	CcSEcCtD
Bicalutamide—Infection—Procarbazine—brain cancer	0.000329	0.00236	CcSEcCtD
Bicalutamide—Hyperglycaemia—Carmustine—brain cancer	0.000329	0.00235	CcSEcCtD
Bicalutamide—Angiopathy—Hydroxyurea—brain cancer	0.000327	0.00234	CcSEcCtD
Bicalutamide—Pneumonia—Carmustine—brain cancer	0.000327	0.00234	CcSEcCtD
Bicalutamide—Shock—Procarbazine—brain cancer	0.000326	0.00233	CcSEcCtD
Bicalutamide—Pollakiuria—Temozolomide—brain cancer	0.000325	0.00233	CcSEcCtD
Bicalutamide—AR—FOXA1 transcription factor network—SHH—brain cancer	0.000325	0.0229	CbGpPWpGaD
Bicalutamide—Erectile dysfunction—Temozolomide—brain cancer	0.000324	0.00232	CcSEcCtD
Bicalutamide—Thrombocytopenia—Procarbazine—brain cancer	0.000324	0.00232	CcSEcCtD
Bicalutamide—Depression—Carmustine—brain cancer	0.000324	0.00232	CcSEcCtD
Bicalutamide—Chills—Hydroxyurea—brain cancer	0.000324	0.00232	CcSEcCtD
Bicalutamide—Weight increased—Temozolomide—brain cancer	0.00032	0.0023	CcSEcCtD
Bicalutamide—Hyperhidrosis—Procarbazine—brain cancer	0.00032	0.00229	CcSEcCtD
Bicalutamide—Alopecia—Hydroxyurea—brain cancer	0.000319	0.00228	CcSEcCtD
Bicalutamide—Weight decreased—Temozolomide—brain cancer	0.000318	0.00228	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Carmustine—brain cancer	0.000318	0.00228	CcSEcCtD
Bicalutamide—Hyperglycaemia—Temozolomide—brain cancer	0.000317	0.00228	CcSEcCtD
Bicalutamide—Urinary tract infection—Carmustine—brain cancer	0.000316	0.00226	CcSEcCtD
Bicalutamide—Pneumonia—Temozolomide—brain cancer	0.000316	0.00226	CcSEcCtD
Bicalutamide—Anorexia—Procarbazine—brain cancer	0.000316	0.00226	CcSEcCtD
Bicalutamide—Depression—Temozolomide—brain cancer	0.000313	0.00224	CcSEcCtD
Bicalutamide—Cardiac arrest—Etoposide—brain cancer	0.00031	0.00222	CcSEcCtD
Bicalutamide—Nausea—Lomustine—brain cancer	0.00031	0.00222	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Temozolomide—brain cancer	0.000308	0.0022	CcSEcCtD
Bicalutamide—Urinary tract infection—Temozolomide—brain cancer	0.000305	0.00219	CcSEcCtD
Bicalutamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000303	0.0214	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000302	0.00216	CcSEcCtD
Bicalutamide—Insomnia—Procarbazine—brain cancer	0.000299	0.00215	CcSEcCtD
Bicalutamide—Paraesthesia—Procarbazine—brain cancer	0.000297	0.00213	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Temozolomide—brain cancer	0.000297	0.00213	CcSEcCtD
Bicalutamide—Sinusitis—Temozolomide—brain cancer	0.000294	0.00211	CcSEcCtD
Bicalutamide—Somnolence—Procarbazine—brain cancer	0.000294	0.00211	CcSEcCtD
Bicalutamide—Haemoglobin—Carmustine—brain cancer	0.000293	0.0021	CcSEcCtD
Bicalutamide—AR—Nuclear Receptors—ESR2—brain cancer	0.000292	0.0206	CbGpPWpGaD
Bicalutamide—Haemorrhage—Carmustine—brain cancer	0.000291	0.00209	CcSEcCtD
Bicalutamide—Anaemia—Hydroxyurea—brain cancer	0.00029	0.00208	CcSEcCtD
Bicalutamide—Decreased appetite—Procarbazine—brain cancer	0.000288	0.00206	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Etoposide—brain cancer	0.000287	0.00206	CcSEcCtD
Bicalutamide—Oedema peripheral—Carmustine—brain cancer	0.000287	0.00206	CcSEcCtD
Bicalutamide—Fatigue—Procarbazine—brain cancer	0.000285	0.00205	CcSEcCtD
Bicalutamide—Haemoglobin—Temozolomide—brain cancer	0.000283	0.00203	CcSEcCtD
Bicalutamide—Constipation—Procarbazine—brain cancer	0.000283	0.00203	CcSEcCtD
Bicalutamide—Pain—Procarbazine—brain cancer	0.000283	0.00203	CcSEcCtD
Bicalutamide—Haemorrhage—Temozolomide—brain cancer	0.000282	0.00202	CcSEcCtD
Bicalutamide—Dysphagia—Etoposide—brain cancer	0.000282	0.00202	CcSEcCtD
Bicalutamide—Visual impairment—Carmustine—brain cancer	0.000281	0.00201	CcSEcCtD
Bicalutamide—Pharyngitis—Temozolomide—brain cancer	0.00028	0.002	CcSEcCtD
Bicalutamide—Urinary tract disorder—Temozolomide—brain cancer	0.000278	0.00199	CcSEcCtD
Bicalutamide—Oedema peripheral—Temozolomide—brain cancer	0.000277	0.00199	CcSEcCtD
Bicalutamide—Urethral disorder—Temozolomide—brain cancer	0.000276	0.00198	CcSEcCtD
Bicalutamide—Feeling abnormal—Procarbazine—brain cancer	0.000273	0.00196	CcSEcCtD
Bicalutamide—Visual impairment—Temozolomide—brain cancer	0.000271	0.00195	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Procarbazine—brain cancer	0.000271	0.00194	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000265	0.0019	CcSEcCtD
Bicalutamide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000265	0.0187	CbGpPWpGaD
Bicalutamide—Neutropenia—Etoposide—brain cancer	0.000263	0.00189	CcSEcCtD
Bicalutamide—Urticaria—Procarbazine—brain cancer	0.000263	0.00188	CcSEcCtD
Bicalutamide—Abdominal pain—Procarbazine—brain cancer	0.000262	0.00188	CcSEcCtD
Bicalutamide—Body temperature increased—Procarbazine—brain cancer	0.000262	0.00188	CcSEcCtD
Bicalutamide—Cardiac disorder—Temozolomide—brain cancer	0.000261	0.00187	CcSEcCtD
Bicalutamide—Arrhythmia—Carmustine—brain cancer	0.00026	0.00187	CcSEcCtD
Bicalutamide—Alopecia—Carmustine—brain cancer	0.000258	0.00185	CcSEcCtD
Bicalutamide—Oedema—Hydroxyurea—brain cancer	0.000256	0.00184	CcSEcCtD
Bicalutamide—Angiopathy—Temozolomide—brain cancer	0.000256	0.00183	CcSEcCtD
Bicalutamide—Mental disorder—Carmustine—brain cancer	0.000255	0.00183	CcSEcCtD
Bicalutamide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000255	0.018	CbGpPWpGaD
Bicalutamide—Infection—Hydroxyurea—brain cancer	0.000255	0.00182	CcSEcCtD
Bicalutamide—Immune system disorder—Temozolomide—brain cancer	0.000254	0.00182	CcSEcCtD
Bicalutamide—Mediastinal disorder—Temozolomide—brain cancer	0.000254	0.00182	CcSEcCtD
Bicalutamide—Malnutrition—Carmustine—brain cancer	0.000254	0.00182	CcSEcCtD
Bicalutamide—Chills—Temozolomide—brain cancer	0.000253	0.00181	CcSEcCtD
Bicalutamide—Pneumonia—Etoposide—brain cancer	0.000253	0.00181	CcSEcCtD
Bicalutamide—Nervous system disorder—Hydroxyurea—brain cancer	0.000251	0.0018	CcSEcCtD
Bicalutamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000251	0.0018	CcSEcCtD
Bicalutamide—Alopecia—Temozolomide—brain cancer	0.000249	0.00178	CcSEcCtD
Bicalutamide—Skin disorder—Hydroxyurea—brain cancer	0.000249	0.00178	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Etoposide—brain cancer	0.000248	0.00177	CcSEcCtD
Bicalutamide—Mental disorder—Temozolomide—brain cancer	0.000247	0.00177	CcSEcCtD
Bicalutamide—Myocardial infarction—Etoposide—brain cancer	0.000246	0.00176	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Etoposide—brain cancer	0.000246	0.00176	CcSEcCtD
Bicalutamide—Back pain—Carmustine—brain cancer	0.000245	0.00176	CcSEcCtD
Bicalutamide—Malnutrition—Temozolomide—brain cancer	0.000245	0.00176	CcSEcCtD
Bicalutamide—Jaundice—Etoposide—brain cancer	0.000245	0.00175	CcSEcCtD
Bicalutamide—Anorexia—Hydroxyurea—brain cancer	0.000244	0.00175	CcSEcCtD
Bicalutamide—Hypersensitivity—Procarbazine—brain cancer	0.000244	0.00175	CcSEcCtD
Bicalutamide—Asthenia—Procarbazine—brain cancer	0.000237	0.0017	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Etoposide—brain cancer	0.000237	0.0017	CcSEcCtD
Bicalutamide—Back pain—Temozolomide—brain cancer	0.000237	0.0017	CcSEcCtD
Bicalutamide—Anaemia—Carmustine—brain cancer	0.000235	0.00168	CcSEcCtD
Bicalutamide—Pruritus—Procarbazine—brain cancer	0.000234	0.00168	CcSEcCtD
Bicalutamide—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000231	0.0163	CbGpPWpGaD
Bicalutamide—Dyspnoea—Hydroxyurea—brain cancer	0.000228	0.00164	CcSEcCtD
Bicalutamide—Somnolence—Hydroxyurea—brain cancer	0.000228	0.00163	CcSEcCtD
Bicalutamide—Anaemia—Temozolomide—brain cancer	0.000227	0.00162	CcSEcCtD
Bicalutamide—Diarrhoea—Procarbazine—brain cancer	0.000226	0.00162	CcSEcCtD
Bicalutamide—Dyspepsia—Hydroxyurea—brain cancer	0.000226	0.00162	CcSEcCtD
Bicalutamide—Angioedema—Temozolomide—brain cancer	0.000224	0.00161	CcSEcCtD
Bicalutamide—Decreased appetite—Hydroxyurea—brain cancer	0.000223	0.0016	CcSEcCtD
Bicalutamide—Urinary tract disorder—Etoposide—brain cancer	0.000223	0.0016	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.000222	0.0157	CbGpPWpGaD
Bicalutamide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000221	0.00159	CcSEcCtD
Bicalutamide—Urethral disorder—Etoposide—brain cancer	0.000221	0.00158	CcSEcCtD
Bicalutamide—Fatigue—Hydroxyurea—brain cancer	0.000221	0.00158	CcSEcCtD
Bicalutamide—Hypertension—Carmustine—brain cancer	0.000219	0.00157	CcSEcCtD
Bicalutamide—Constipation—Hydroxyurea—brain cancer	0.000219	0.00157	CcSEcCtD
Bicalutamide—Pain—Hydroxyurea—brain cancer	0.000219	0.00157	CcSEcCtD
Bicalutamide—Dizziness—Procarbazine—brain cancer	0.000219	0.00157	CcSEcCtD
Bicalutamide—Chest pain—Carmustine—brain cancer	0.000216	0.00155	CcSEcCtD
Bicalutamide—Myalgia—Carmustine—brain cancer	0.000216	0.00155	CcSEcCtD
Bicalutamide—Anxiety—Carmustine—brain cancer	0.000215	0.00154	CcSEcCtD
Bicalutamide—Cough—Temozolomide—brain cancer	0.000214	0.00153	CcSEcCtD
Bicalutamide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000212	0.0149	CbGpPWpGaD
Bicalutamide—Hypertension—Temozolomide—brain cancer	0.000212	0.00152	CcSEcCtD
Bicalutamide—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.000212	0.0149	CbGpPWpGaD
Bicalutamide—Feeling abnormal—Hydroxyurea—brain cancer	0.000211	0.00151	CcSEcCtD
Bicalutamide—Vomiting—Procarbazine—brain cancer	0.00021	0.00151	CcSEcCtD
Bicalutamide—Cardiac disorder—Etoposide—brain cancer	0.000209	0.0015	CcSEcCtD
Bicalutamide—Confusional state—Carmustine—brain cancer	0.000209	0.0015	CcSEcCtD
Bicalutamide—Myalgia—Temozolomide—brain cancer	0.000209	0.0015	CcSEcCtD
Bicalutamide—Rash—Procarbazine—brain cancer	0.000209	0.0015	CcSEcCtD
Bicalutamide—Dermatitis—Procarbazine—brain cancer	0.000209	0.00149	CcSEcCtD
Bicalutamide—Anxiety—Temozolomide—brain cancer	0.000208	0.00149	CcSEcCtD
Bicalutamide—Headache—Procarbazine—brain cancer	0.000207	0.00149	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000207	0.00149	CcSEcCtD
Bicalutamide—Oedema—Carmustine—brain cancer	0.000207	0.00148	CcSEcCtD
Bicalutamide—Infection—Carmustine—brain cancer	0.000206	0.00147	CcSEcCtD
Bicalutamide—Angiopathy—Etoposide—brain cancer	0.000205	0.00147	CcSEcCtD
Bicalutamide—Dry mouth—Temozolomide—brain cancer	0.000204	0.00146	CcSEcCtD
Bicalutamide—Immune system disorder—Etoposide—brain cancer	0.000204	0.00146	CcSEcCtD
Bicalutamide—Mediastinal disorder—Etoposide—brain cancer	0.000203	0.00146	CcSEcCtD
Bicalutamide—Thrombocytopenia—Carmustine—brain cancer	0.000203	0.00145	CcSEcCtD
Bicalutamide—Body temperature increased—Hydroxyurea—brain cancer	0.000203	0.00145	CcSEcCtD
Bicalutamide—Chills—Etoposide—brain cancer	0.000202	0.00145	CcSEcCtD
Bicalutamide—Confusional state—Temozolomide—brain cancer	0.000202	0.00145	CcSEcCtD
Bicalutamide—Oedema—Temozolomide—brain cancer	0.0002	0.00143	CcSEcCtD
Bicalutamide—Alopecia—Etoposide—brain cancer	0.000199	0.00143	CcSEcCtD
Bicalutamide—Infection—Temozolomide—brain cancer	0.000199	0.00143	CcSEcCtD
Bicalutamide—Anorexia—Carmustine—brain cancer	0.000197	0.00141	CcSEcCtD
Bicalutamide—Nausea—Procarbazine—brain cancer	0.000197	0.00141	CcSEcCtD
Bicalutamide—Nervous system disorder—Temozolomide—brain cancer	0.000196	0.00141	CcSEcCtD
Bicalutamide—Thrombocytopenia—Temozolomide—brain cancer	0.000196	0.0014	CcSEcCtD
Bicalutamide—Skin disorder—Temozolomide—brain cancer	0.000194	0.00139	CcSEcCtD
Bicalutamide—Hyperhidrosis—Temozolomide—brain cancer	0.000193	0.00139	CcSEcCtD
Bicalutamide—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000192	0.0135	CbGpPWpGaD
Bicalutamide—Anorexia—Temozolomide—brain cancer	0.000191	0.00137	CcSEcCtD
Bicalutamide—Back pain—Etoposide—brain cancer	0.00019	0.00136	CcSEcCtD
Bicalutamide—Hypersensitivity—Hydroxyurea—brain cancer	0.000189	0.00135	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000189	0.00135	CcSEcCtD
Bicalutamide—Muscle spasms—Etoposide—brain cancer	0.000189	0.00135	CcSEcCtD
Bicalutamide—Insomnia—Carmustine—brain cancer	0.000187	0.00134	CcSEcCtD
Bicalutamide—Paraesthesia—Carmustine—brain cancer	0.000186	0.00133	CcSEcCtD
Bicalutamide—Dyspnoea—Carmustine—brain cancer	0.000185	0.00132	CcSEcCtD
Bicalutamide—Somnolence—Carmustine—brain cancer	0.000184	0.00132	CcSEcCtD
Bicalutamide—Asthenia—Hydroxyurea—brain cancer	0.000184	0.00132	CcSEcCtD
Bicalutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000183	0.0129	CbGpPWpGaD
Bicalutamide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000182	0.00131	CcSEcCtD
Bicalutamide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000182	0.0128	CbGpPWpGaD
Bicalutamide—Anaemia—Etoposide—brain cancer	0.000181	0.0013	CcSEcCtD
Bicalutamide—Insomnia—Temozolomide—brain cancer	0.000181	0.0013	CcSEcCtD
Bicalutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000181	0.0127	CbGpPWpGaD
Bicalutamide—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000181	0.0127	CbGpPWpGaD
Bicalutamide—Decreased appetite—Carmustine—brain cancer	0.00018	0.00129	CcSEcCtD
Bicalutamide—Paraesthesia—Temozolomide—brain cancer	0.00018	0.00129	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Carmustine—brain cancer	0.000179	0.00128	CcSEcCtD
Bicalutamide—Dyspnoea—Temozolomide—brain cancer	0.000178	0.00128	CcSEcCtD
Bicalutamide—Somnolence—Temozolomide—brain cancer	0.000178	0.00128	CcSEcCtD
Bicalutamide—Constipation—Carmustine—brain cancer	0.000177	0.00127	CcSEcCtD
Bicalutamide—Pain—Carmustine—brain cancer	0.000177	0.00127	CcSEcCtD
Bicalutamide—Dyspepsia—Temozolomide—brain cancer	0.000176	0.00126	CcSEcCtD
Bicalutamide—Diarrhoea—Hydroxyurea—brain cancer	0.000175	0.00126	CcSEcCtD
Bicalutamide—Decreased appetite—Temozolomide—brain cancer	0.000174	0.00125	CcSEcCtD
Bicalutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000174	0.0122	CbGpPWpGaD
Bicalutamide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000173	0.00124	CcSEcCtD
Bicalutamide—Fatigue—Temozolomide—brain cancer	0.000173	0.00124	CcSEcCtD
Bicalutamide—Loss of consciousness—Etoposide—brain cancer	0.000172	0.00124	CcSEcCtD
Bicalutamide—Cough—Etoposide—brain cancer	0.000171	0.00123	CcSEcCtD
Bicalutamide—Pain—Temozolomide—brain cancer	0.000171	0.00123	CcSEcCtD
Bicalutamide—Constipation—Temozolomide—brain cancer	0.000171	0.00123	CcSEcCtD
Bicalutamide—Feeling abnormal—Carmustine—brain cancer	0.000171	0.00122	CcSEcCtD
Bicalutamide—Hypertension—Etoposide—brain cancer	0.000169	0.00121	CcSEcCtD
Bicalutamide—Dizziness—Hydroxyurea—brain cancer	0.000169	0.00121	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Carmustine—brain cancer	0.000169	0.00121	CcSEcCtD
Bicalutamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000169	0.0119	CbGpPWpGaD
Bicalutamide—Chest pain—Etoposide—brain cancer	0.000167	0.0012	CcSEcCtD
Bicalutamide—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000166	0.0117	CbGpPWpGaD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000166	0.00119	CcSEcCtD
Bicalutamide—Feeling abnormal—Temozolomide—brain cancer	0.000165	0.00118	CcSEcCtD
Bicalutamide—Body temperature increased—Carmustine—brain cancer	0.000164	0.00117	CcSEcCtD
Bicalutamide—Abdominal pain—Carmustine—brain cancer	0.000164	0.00117	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Temozolomide—brain cancer	0.000164	0.00117	CcSEcCtD
Bicalutamide—Vomiting—Hydroxyurea—brain cancer	0.000163	0.00117	CcSEcCtD
Bicalutamide—Rash—Hydroxyurea—brain cancer	0.000162	0.00116	CcSEcCtD
Bicalutamide—Confusional state—Etoposide—brain cancer	0.000161	0.00116	CcSEcCtD
Bicalutamide—Dermatitis—Hydroxyurea—brain cancer	0.000161	0.00116	CcSEcCtD
Bicalutamide—Headache—Hydroxyurea—brain cancer	0.00016	0.00115	CcSEcCtD
Bicalutamide—Infection—Etoposide—brain cancer	0.000159	0.00114	CcSEcCtD
Bicalutamide—Urticaria—Temozolomide—brain cancer	0.000159	0.00114	CcSEcCtD
Bicalutamide—Body temperature increased—Temozolomide—brain cancer	0.000158	0.00113	CcSEcCtD
Bicalutamide—Abdominal pain—Temozolomide—brain cancer	0.000158	0.00113	CcSEcCtD
Bicalutamide—Thrombocytopenia—Etoposide—brain cancer	0.000157	0.00112	CcSEcCtD
Bicalutamide—Skin disorder—Etoposide—brain cancer	0.000156	0.00111	CcSEcCtD
Bicalutamide—Hyperhidrosis—Etoposide—brain cancer	0.000155	0.00111	CcSEcCtD
Bicalutamide—Anorexia—Etoposide—brain cancer	0.000153	0.00109	CcSEcCtD
Bicalutamide—Hypersensitivity—Carmustine—brain cancer	0.000153	0.00109	CcSEcCtD
Bicalutamide—Nausea—Hydroxyurea—brain cancer	0.000152	0.00109	CcSEcCtD
Bicalutamide—Asthenia—Carmustine—brain cancer	0.000149	0.00107	CcSEcCtD
Bicalutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000149	0.0105	CbGpPWpGaD
Bicalutamide—Hypersensitivity—Temozolomide—brain cancer	0.000147	0.00106	CcSEcCtD
Bicalutamide—Paraesthesia—Etoposide—brain cancer	0.000144	0.00103	CcSEcCtD
Bicalutamide—Asthenia—Temozolomide—brain cancer	0.000144	0.00103	CcSEcCtD
Bicalutamide—Dyspnoea—Etoposide—brain cancer	0.000143	0.00102	CcSEcCtD
Bicalutamide—Somnolence—Etoposide—brain cancer	0.000142	0.00102	CcSEcCtD
Bicalutamide—Diarrhoea—Carmustine—brain cancer	0.000142	0.00102	CcSEcCtD
Bicalutamide—Pruritus—Temozolomide—brain cancer	0.000142	0.00101	CcSEcCtD
Bicalutamide—Decreased appetite—Etoposide—brain cancer	0.000139	0.000998	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Etoposide—brain cancer	0.000138	0.000991	CcSEcCtD
Bicalutamide—Fatigue—Etoposide—brain cancer	0.000138	0.00099	CcSEcCtD
Bicalutamide—Dizziness—Carmustine—brain cancer	0.000137	0.000982	CcSEcCtD
Bicalutamide—Pain—Etoposide—brain cancer	0.000137	0.000982	CcSEcCtD
Bicalutamide—Constipation—Etoposide—brain cancer	0.000137	0.000982	CcSEcCtD
Bicalutamide—Diarrhoea—Temozolomide—brain cancer	0.000137	0.000981	CcSEcCtD
Bicalutamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000137	0.00963	CbGpPWpGaD
Bicalutamide—Dizziness—Temozolomide—brain cancer	0.000132	0.000949	CcSEcCtD
Bicalutamide—Feeling abnormal—Etoposide—brain cancer	0.000132	0.000946	CcSEcCtD
Bicalutamide—Vomiting—Carmustine—brain cancer	0.000132	0.000944	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Etoposide—brain cancer	0.000131	0.000939	CcSEcCtD
Bicalutamide—Rash—Carmustine—brain cancer	0.000131	0.000936	CcSEcCtD
Bicalutamide—Dermatitis—Carmustine—brain cancer	0.00013	0.000935	CcSEcCtD
Bicalutamide—Headache—Carmustine—brain cancer	0.00013	0.00093	CcSEcCtD
Bicalutamide—Vomiting—Temozolomide—brain cancer	0.000127	0.000912	CcSEcCtD
Bicalutamide—Urticaria—Etoposide—brain cancer	0.000127	0.000912	CcSEcCtD
Bicalutamide—Abdominal pain—Etoposide—brain cancer	0.000127	0.000907	CcSEcCtD
Bicalutamide—Body temperature increased—Etoposide—brain cancer	0.000127	0.000907	CcSEcCtD
Bicalutamide—Rash—Temozolomide—brain cancer	0.000126	0.000904	CcSEcCtD
Bicalutamide—Dermatitis—Temozolomide—brain cancer	0.000126	0.000904	CcSEcCtD
Bicalutamide—Headache—Temozolomide—brain cancer	0.000125	0.000899	CcSEcCtD
Bicalutamide—Nausea—Carmustine—brain cancer	0.000123	0.000882	CcSEcCtD
Bicalutamide—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000119	0.00841	CbGpPWpGaD
Bicalutamide—Nausea—Temozolomide—brain cancer	0.000119	0.000852	CcSEcCtD
Bicalutamide—Hypersensitivity—Etoposide—brain cancer	0.000118	0.000846	CcSEcCtD
Bicalutamide—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000118	0.0083	CbGpPWpGaD
Bicalutamide—Asthenia—Etoposide—brain cancer	0.000115	0.000824	CcSEcCtD
Bicalutamide—Pruritus—Etoposide—brain cancer	0.000113	0.000812	CcSEcCtD
Bicalutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00011	0.00777	CbGpPWpGaD
Bicalutamide—Diarrhoea—Etoposide—brain cancer	0.00011	0.000785	CcSEcCtD
Bicalutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000109	0.00767	CbGpPWpGaD
Bicalutamide—Dizziness—Etoposide—brain cancer	0.000106	0.000759	CcSEcCtD
Bicalutamide—Vomiting—Etoposide—brain cancer	0.000102	0.00073	CcSEcCtD
Bicalutamide—Rash—Etoposide—brain cancer	0.000101	0.000724	CcSEcCtD
Bicalutamide—Dermatitis—Etoposide—brain cancer	0.000101	0.000723	CcSEcCtD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.0001	0.00708	CbGpPWpGaD
Bicalutamide—Headache—Etoposide—brain cancer	0.0001	0.000719	CcSEcCtD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	9.72e-05	0.00685	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	9.52e-05	0.00671	CbGpPWpGaD
Bicalutamide—Nausea—Etoposide—brain cancer	9.51e-05	0.000682	CcSEcCtD
Bicalutamide—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	9.45e-05	0.00666	CbGpPWpGaD
Bicalutamide—CYP3A4—Irinotecan Pathway—APC—brain cancer	9.36e-05	0.0066	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	9.32e-05	0.00657	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	9.24e-05	0.00652	CbGpPWpGaD
Bicalutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.93e-05	0.0063	CbGpPWpGaD
Bicalutamide—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	8.38e-05	0.00591	CbGpPWpGaD
Bicalutamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	8.3e-05	0.00585	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	8.04e-05	0.00567	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	7.97e-05	0.00562	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	7.89e-05	0.00556	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	7.88e-05	0.00555	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	7.81e-05	0.00551	CbGpPWpGaD
Bicalutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	7.8e-05	0.0055	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	7.78e-05	0.00549	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	7.51e-05	0.00529	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—HES1—brain cancer	7.34e-05	0.00517	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP2C9—brain cancer	7.26e-05	0.00512	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	7.16e-05	0.00505	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—RELA—brain cancer	6.63e-05	0.00468	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	6.6e-05	0.00465	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.47e-05	0.00456	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.39e-05	0.00451	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	6.34e-05	0.00447	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	6.28e-05	0.00443	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.94e-05	0.00419	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	5.91e-05	0.00416	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—CCND1—brain cancer	5.82e-05	0.00411	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	5.77e-05	0.00407	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.66e-05	0.00399	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	5.09e-05	0.00359	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	5.04e-05	0.00355	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—STAT3—brain cancer	5.03e-05	0.00354	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.89e-05	0.00345	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.75e-05	0.00335	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.68e-05	0.0033	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.61e-05	0.00325	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—EGFR—brain cancer	4.57e-05	0.00322	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—ESR2—brain cancer	3.99e-05	0.00281	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	3.81e-05	0.00269	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NOTCH2—brain cancer	3.78e-05	0.00267	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	3.78e-05	0.00266	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.68e-05	0.00259	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.58e-05	0.00252	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	3.33e-05	0.00234	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.24e-05	0.00228	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.16e-05	0.00223	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.13e-05	0.00221	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	3.06e-05	0.00216	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.03e-05	0.00214	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	2.99e-05	0.00211	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.76e-05	0.00194	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.54e-05	0.00179	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	2.51e-05	0.00177	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.48e-05	0.00175	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.22e-05	0.00156	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—DNMT1—brain cancer	2.14e-05	0.00151	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.08e-05	0.00147	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.02e-05	0.00142	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ESR2—brain cancer	1.92e-05	0.00136	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NOTCH2—brain cancer	1.82e-05	0.00128	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SIRT1—brain cancer	1.55e-05	0.00109	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP2C9—brain cancer	1.35e-05	0.000951	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MYC—brain cancer	1.26e-05	0.000888	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP2C9—brain cancer	1.24e-05	0.000875	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—BSG—brain cancer	1.15e-05	0.000809	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—BSG—brain cancer	1.06e-05	0.000744	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—BSG—brain cancer	1.05e-05	0.000738	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—IDH1—brain cancer	9.87e-06	0.000696	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—IDH1—brain cancer	9.08e-06	0.00064	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—IDH1—brain cancer	9e-06	0.000634	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP2C9—brain cancer	8.12e-06	0.000572	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.03e-06	0.000566	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ENO2—brain cancer	7.8e-06	0.00055	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.33e-06	0.000516	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ENO2—brain cancer	7.17e-06	0.000506	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ENO2—brain cancer	7.11e-06	0.000501	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BSG—brain cancer	6.9e-06	0.000486	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—brain cancer	6.06e-06	0.000428	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—IDH1—brain cancer	5.93e-06	0.000418	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ENO2—brain cancer	4.69e-06	0.000331	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—brain cancer	3.58e-06	0.000252	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—brain cancer	3.29e-06	0.000232	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—brain cancer	3.26e-06	0.00023	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—brain cancer	2.15e-06	0.000152	CbGpPWpGaD
